Lv1
50 积分 2024-09-19 加入
PD-L1 expression and Tumor mutation burden as Pathological response biomarkers of Neoadjuvant immunotherapy for Early-stage Non-small cell lung cancer: A systematic review and meta-analysis
12天前
已完结
Targeted therapy for non‐small‐cell lung cancer: New insights into regulated cell death combined with immunotherapy
12天前
已完结
VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives
23天前
已完结
Immune Checkpoint Inhibitors Rechallenge in Non-Small Cell Lung Cancer: Current Evidence and Future Directions
1个月前
已完结
A case of proliferative glomerulosclerosis with compound heterozygous TTC21B mutations
2个月前
已完结
皖公网安备34019202002308
